| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | CA2491029A1 Substituted aryl boronic acids, their preparation and their precursors |
| 01/14/2004 | EP1380569A1 Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery |
| 01/14/2004 | EP1380568A2 Perfluoroalkylaniline derivatives |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379492A1 Inhibitor of monoamine uptake |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | CN1468502A Organic electroluminescent devices |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine |
| 01/13/2004 | US6677485 Process for the preparation of fluoxetine hydrochloride |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677341 (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | CA2053359C Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 01/08/2004 | WO2004002947A1 Phenoxypropenylphenyl derivatives and their use as herbicides |
| 01/08/2004 | WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
| 01/08/2004 | US20040006224 Synthesis of 2-alkyl amino acids |
| 01/08/2004 | US20040006143 Aminoalcohol derivatives |
| 01/08/2004 | US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia |
| 01/08/2004 | US20040006102 Alkoxy aryl beta2 adrenergic receptor agonists |
| 01/08/2004 | US20040006061 Suitable for the antimicrobial treatment of surfaces, as antimicrobial active substances against gram-positive and gram-negative bacteria |
| 01/08/2004 | US20040005984 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 01/08/2004 | CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377536A1 Self-reducing anthraquinone compounds |
| 01/07/2004 | CN1466567A Substituted 1-aminobutan-3-01 derivatives |
| 01/06/2004 | US6673934 4-amino-2-(1-aryloxy-ethyl)phenol compound |
| 01/06/2004 | US6673932 Primary intermediates for oxidative coloration of hair |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/02/2004 | EP1375562A1 Diaminobenzene derivatives, polyimide precursors and polyimides prepared by using tha same, and liquid crystal aligning agents |
| 01/02/2004 | EP1375536A1 Process for the preparation of polyalkylphenoxyaminoalkanes |
| 01/02/2004 | EP1375471A1 Bis-o-amino(thio)phenols and their preparation |
| 01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
| 01/02/2004 | EP1077923B1 An improved synthesis and purification of (r*,r*)-2- (dimethylamino) methyl]-1-( 3-methoxyphenyl) cyclohexanol hydrochloride |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002549 Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them |
| 01/01/2004 | US20040000471 Storage stability; discoloration inhibition; mixing with ethyleneamine; distillation |
| 12/31/2003 | WO2004000783A1 Aminoalkylphenols, methods of using and making the same |
| 12/31/2003 | WO2004000762A2 Propionic acid derivatives and their use as hppars activators |
| 12/31/2003 | WO2004000302A1 Novel resveratrol analogs |
| 12/31/2003 | CA2489359A1 Propionic acid derivatives and their use as hppars activators |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group |
| 12/30/2003 | US6669937 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
| 12/30/2003 | CA2051399C Therapeutically useful 2-aminotetralin derivatives |
| 12/25/2003 | US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester |
| 12/25/2003 | US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine |
| 12/25/2003 | US20030236426 Synthesis of benzimidate from benzoic acid |
| 12/25/2003 | US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis |
| 12/25/2003 | US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders |
| 12/25/2003 | US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 12/25/2003 | US20030236225 Substituted ethylene diamines for the treatment of infectious diseases; used for mycobacterial infections, including tuberculosis |
| 12/23/2003 | US6667413 Uracil compounds and use thereof |
| 12/18/2003 | WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 12/18/2003 | WO2003103609A2 Novel trifluoromethylepinephrine compounds and methods of making and using thereof |
| 12/18/2003 | WO2002067916A3 Pharmaceutical salts |
| 12/18/2003 | US20030232891 For therapy of pain |
| 12/18/2003 | US20030232886 For resolving racemic mixtures; chemical intermediates, drugs |
| 12/18/2003 | CA2483141A1 Novel trifluoromethylepinephrine compounds and methods of making and using thereof |
| 12/17/2003 | EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds |
| 12/17/2003 | EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 12/17/2003 | EP1370255A2 Cdc25 phosphatase inhibitors |
| 12/17/2003 | CN1131203C Method for separating tramadol raceme |
| 12/17/2003 | CN1131202C Calcium receptor-active compounds |
| 12/16/2003 | US6664425 Process for producing 1,3-bis(3-aminophenoxy)benzene |
| 12/11/2003 | WO2003102045A1 Hybrid polymer materials for liquid crystal alignment layers |
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101931A2 Preparation of 4-(n, n-disubstitutedamino) butyraldehyde acetals |
| 12/11/2003 | WO2003101440A1 Metabolite of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentane-3-ol and the use thereof in the treatment of urinary incontinence |
| 12/11/2003 | WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 12/11/2003 | US20030229231 Forming chelate compounds |
| 12/11/2003 | US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 12/11/2003 | US20030229073 Tricyclic compounds and method of treating herpes virus |
| 12/11/2003 | US20030229058 Aryl aniline beta2 adrenergic receptor agonists |
| 12/11/2003 | US20030228998 Polyamine in mixture with surfactants; cleaning fabrics |
| 12/11/2003 | CA2487957A1 An improved process for the preparation of 4-(n, n-disubstitutedamino) butyraldehyde acetals |
| 12/11/2003 | CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/10/2003 | EP1368408A1 Oxalkylation products produced from epoxides and amines and their use in pigment preparations |
| 12/10/2003 | EP1368299A2 Substituted c-cyclohexylmethylamine derivatives |
| 12/10/2003 | EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases |
| 12/10/2003 | EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS |
| 12/09/2003 | US6660879 Use of the compound in clinical conditions associated with insulin resistance. |
| 12/04/2003 | WO2003099776A1 Calcium receptor modulating arylalkylamines |
| 12/04/2003 | WO2003099769A1 Anilino liver x-receptor modulators |
| 12/04/2003 | WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS |
| 12/04/2003 | WO2003099273A1 Adduct of topiramate and tramadol hydrochloride and uses thereof |
| 12/04/2003 | WO2003099192A2 Bis-aromatic alkanols |
| 12/04/2003 | WO2003063790A3 Additives and products including oligoesters |
| 12/04/2003 | WO2003020686A3 Method for producing 4-amino-1-naphthol ethers |
| 12/04/2003 | US20030225287 Synthesis of chiral 2-alkyl amino acids |
| 12/04/2003 | US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 12/04/2003 | US20030225059 Cyclohexyl derivatives and their use as therapeutic agents |
| 12/04/2003 | CA2486853A1 Bis-aromatic alkanols |